Archive for the ‘biotech/medical’ category: Page 1951
Nov 7, 2019
Dr. David Sinclair on Informational Theory of Aging, Nicotinamide Mononucleotide, Resveratrol & More
Posted by Paul Battista in categories: biotech/medical, genetics, life extension
David A. Sinclair, PhD, is a professor in the Department of Genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for the Biological Mechanisms of Aging.
Dr. Sinclair’s work focuses on understanding the mechanisms that drive human aging and identifying ways to slow or reverse aging’s effects. In particular, he has examined the role of sirtuins in disease and aging, with special emphasis on how sirtuin activity is modulated by compounds produced by the body as well as those consumed in the diet, such as resveratrol. His work has implications for human metabolism, mitochondrial and neurological health, and cancer.
▶︎ Get the episode’s show notes, timeline, and transcript.
https://www.foundmyfitness.com/episodes/david-sinclair
Nov 7, 2019
First use of CRISPR against cancer in patients clears safety hurdles
Posted by Paul Battista in categories: bioengineering, biotech/medical, genetics
The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival, doctors reported Wednesday.
The doctors were able to take immune system cells from the patients’ blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects. The treatment deletes three genes that might have been hindering these cells’ ability to attack the disease, and adds a new, fourth feature to help them do the job.
“It’s the most complicated genetic, cellular engineering that’s been attempted so far,” said the study leader, Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia. “This is proof that we can safely do gene editing of these cells.”
Nov 7, 2019
Revamped cancer drug starves tumors in mice
Posted by Genevieve Klien in category: biotech/medical
Nov 7, 2019
This Scientist Wants to Gene-Hack Hybrid Humans to Survive Mars
Posted by Quinn Sena in categories: biotech/medical, genetics, space
Nov 7, 2019
There’s A Promising New Vaccine For One Of The World’s Top Health Threats
Posted by Genevieve Klien in categories: biotech/medical, health
Scientists Announce Promising New Dengue Vaccine : Goats and Soda Dengue afflicts nearly 400 million people worldwide every year, but a vaccine has remained elusive. New research offers a path forward.
Nov 7, 2019
This Intelligent Microrobot Bird Could Navigate Through Blood Stream And Kill Cancer Cells
Posted by Genevieve Klien in categories: biotech/medical, futurism
Nov 6, 2019
Theoretical spin battery could see magnet powered cars
Posted by Quinn Sena in categories: biotech/medical, chemistry, computing, nanotechnology, sustainability
Circa 2009
March 19, 2009 Researchers at the University of Miami and at the Universities of Tokyo and Tohoku, Japan, have been able to prove the existence of a “spin battery,” that could have significant applications including much faster, less expensive and use less energy consuming computer hard drives with no moving parts, and could even be developed to power cars.
A “spin battery” is “charged” by applying a large magnetic field to nano-magnets in a device called a magnetic tunnel junction (MTJ). Like a toy car, the spin battery is “wound up” by applying a large magnetic field — no chemistry involved.
Continue reading “Theoretical spin battery could see magnet powered cars” »
Nov 6, 2019
Scientists discover first new HIV strain in nearly two decades
Posted by Genevieve Klien in category: biotech/medical
The strain is a part of the Group M version of HIV-1, the same family of virus subtypes to blame for the global HIV pandemic, according to Abbott Laboratories, which conducted the research along with the University of Missouri, Kansas City. The findings were published Wednesday in the Journal of Acquired Immune Deficiency Syndromes.
Nov 6, 2019
2019’s Allen Distinguished Investigators will focus on the mysteries of our cells
Posted by Genevieve Klien in category: biotech/medical
The Paul G. Allen Frontiers Group, a division of Seattle’s Allen Institute, is making a total of $7.5 million in awards to its latest class of five biomedical researchers.
The themes for this year’s Allen Distinguished Investigators focus on stem cell therapies and single-cell interactions in their native environments.
“The field of stem cell biology has the potential to change how we treat diseases by helping precision medicine, and there’s so much we still don’t understand about the interplay between cells in living tissues or organs,” Kathy Richmond, director of the Frontiers Group, said today in a news release.